Table 2 Primary and secondary outcomes in two groups
Outcomes | PLT > 49.5 × 10^9/L (n = 167) | PLT ≤ 49.5 × 10^9/L (n = 162) | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|---|---|
p | OR (95% CI) | p | OR (95% CI) | |||
Portal vein complications (%) | 21 (12.6%) | 3 (1.9%) | < 0.001 | 7.623 (2.227, 26.091) | 0.002 | 8.821 (2.260, 34.437) |
 Hepatic artery thrombosis (%) | 5 (3.0%) | 4 (2.5%) | 0.770 | 1.219 (0.321, 4.623) |  |  |
 Biliary strictures (%) | 22 (13.2%) | 22 (13.6%) | 0.914 | 0.966 (0.512, 1.822) |  |  |
 Early allograft dysfunction (%) | 36 (22.0%) | 26 (16.4%) | 0.203 | 1.439 (0.822, 2.518) |  |  |
In-hospital mortality (%) | 9 (5.4%) | 6 (3.7%) | 0.464 | 1.481 (0.515, 4.260) | Â | Â |
Prolonged ICU stay (%) | 74 (44.3%) | 63 (38.9%) | 0.319 | 1.250 (0.806, 1.940) | Â | Â |
Post-operative hospital stay (days) | 17 (14, 22) | 18 (14, 24) | 0.445 | / | Â | Â |